381 related articles for article (PubMed ID: 34054717)
21. Correlation of Serum Estradiol with Bone Mineral Density and Bone Metabolism in Patients of Postmenopausal Type 2 Diabetes Mellitus Complicated with Osteoporosis.
Yang F; Xu Q
Horm Metab Res; 2022 Jul; 54(7):442-449. PubMed ID: 35835144
[TBL] [Abstract][Full Text] [Related]
22. The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.
Gossiel F; Ugur A; Peel NFA; Walsh JS; Eastell R
Osteoporos Int; 2022 Jun; 33(6):1357-1363. PubMed ID: 35102444
[TBL] [Abstract][Full Text] [Related]
23. Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients.
Guo H; Wang C; Jiang B; Ge S; Cai J; Zhou Y; Ying R; Zha K; Zhou J; Wang N; Zhu C; Cao C; Zhang L; Gu T; Zhao Y; Lu Y; An Z
Front Endocrinol (Lausanne); 2021; 12():554604. PubMed ID: 33841321
[TBL] [Abstract][Full Text] [Related]
24. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
[TBL] [Abstract][Full Text] [Related]
25. Bone turnover in passive smoking female rat: relationships to change in bone mineral density.
Gao SG; Li KH; Xu M; Jiang W; Shen H; Luo W; Xu WS; Tian J; Lei GH
BMC Musculoskelet Disord; 2011 Jun; 12():131. PubMed ID: 21663694
[TBL] [Abstract][Full Text] [Related]
26. Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women.
Yoshii I; Chijiwa T; Sawada N
J Orthop Sci; 2020 Jul; 25(4):671-676. PubMed ID: 31337577
[TBL] [Abstract][Full Text] [Related]
27. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
[TBL] [Abstract][Full Text] [Related]
28. Correlation Between Serum miR-154-5p and Osteocalcin in Males and Postmenopausal Females of Type 2 Diabetes With Different Urinary Albumin Creatinine Ratios.
Ren H; Ma X; Shao Y; Han J; Yang M; Wang Q
Front Endocrinol (Lausanne); 2019; 10():542. PubMed ID: 31447785
[No Abstract] [Full Text] [Related]
29. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation.
Avbersek-Luznik I; Gmeiner Stopar T; Marc J
Clin Chem Lab Med; 2007; 45(8):1014-8. PubMed ID: 17579570
[TBL] [Abstract][Full Text] [Related]
30. LncRNAp21 promotes osteogenic differentiation of mesenchymal stem cells in the rat model of osteoporosis by the Wnt/β-catenin signaling pathway.
Yang K; Tian N; Liu H; Tao XZ; Wang MX; Huang W
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4303-4309. PubMed ID: 31173302
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Bone Turnover Biomarkers in Lead-Battery Workers with Long-Term Exposure to Lead.
Kalahasthi R; Barman T; Bagepally BS
Int J Occup Environ Med; 2020 Jul; 11(3):140-147. PubMed ID: 32683426
[TBL] [Abstract][Full Text] [Related]
32. Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis.
Huang N; Zhou J; Wang W; Wang Q; Tang Y; Sun Y; Wang D; Chen S
Clin Endocrinol (Oxf); 2018 May; 88(5):659-664. PubMed ID: 29394455
[TBL] [Abstract][Full Text] [Related]
33. Association between serum ferritin and bone turnover marker levels in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease.
Chen C; Zhao Y; Lv X; Li K; Wang Y; Ma D; Han M; Zan X; Guo X; Liu J
Postgrad Med; 2024 Apr; 136(3):292-301. PubMed ID: 38511546
[TBL] [Abstract][Full Text] [Related]
34. Increased bone resorption that outpaces increased bone formation: An important pathology of rapidly destructive coxarthrosis.
Watanabe N; Ogawa T; Miyatake K; Takada R; Jinno T; Koga H; Yoshii T
J Orthop Res; 2024 May; 42(5):1066-1073. PubMed ID: 38044471
[TBL] [Abstract][Full Text] [Related]
35. Bone turnover biomarkers in obese postmenopausal Saudi women with type-II diabetes mellitus.
Alselami NM; Noureldeen AF; Al-Ghamdi MA; Khan JA; Moselhy SS
Afr Health Sci; 2015 Mar; 15(1):90-6. PubMed ID: 25834535
[TBL] [Abstract][Full Text] [Related]
36. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease].
Peng F; Fu R; Liu H; Wang Y; Ding K; Ding S; Liu Z; Ruan E; Qu W; Wang H; Xing L; Wang X; Wang G; Song J; Wu Y; Li L; Liu H; Guan J; Shao Z
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(42):3436-9. PubMed ID: 26813134
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y
J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182
[TBL] [Abstract][Full Text] [Related]
39. Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia.
Du X; Ye F; Li J; Zhao Y; Xiao W; Tang X; Zhang X
Sci Rep; 2020 Aug; 10(1):13598. PubMed ID: 32788631
[TBL] [Abstract][Full Text] [Related]
40. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
